Ventricular Tachycardia Ablation for Ventricular Tachycardia

Phase-Based Progress Estimates
Saint Luke's Hospital of Kansas City, Kansas City, MOVentricular TachycardiaVentricular Tachycardia Ablation - Procedure
18 - 80
All Sexes
What conditions do you have?

Study Summary

This trial is testing whether a single shock from an implantable cardioverter defibrillator (ICD) is best treated with medication, ablation, or no intervention.

Eligible Conditions
  • Ventricular Tachycardia

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 7 Secondary · Reporting Duration: 12 months

12 months
ATP Therapy as recorded by ICD
ICD Shocks
Initiation of antiarrythmic medication
Modification of antiarrythmic medication
Non-sustained VT
Repeat ablation
Total Mortality

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Standard medical therapy
1 of 2
Ventricular Tachycardia Ablation
1 of 2

Active Control

Experimental Treatment

75 Total Participants · 2 Treatment Groups

Primary Treatment: Ventricular Tachycardia Ablation · No Placebo Group · N/A

Ventricular Tachycardia AblationExperimental Group · 2 Interventions: Ventricular Tachycardia Ablation, Non-Invasive Programmed Stimulation (NIPS) · Intervention Types: Procedure, Procedure
Standard medical therapyActiveComparator Group · 2 Interventions: Standard Medical Therapy, Non-Invasive Programmed Stimulation (NIPS) · Intervention Types: Other, Procedure

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 12 months

Who is running the clinical trial?

Sanjaya GuptaLead Sponsor
2 Previous Clinical Trials
534 Total Patients Enrolled
Saint Luke's Health SystemLead Sponsor
40 Previous Clinical Trials
15,354 Total Patients Enrolled
MedtronicIndustry Sponsor
579 Previous Clinical Trials
748,362 Total Patients Enrolled
Sanjaya Gupta, MDPrincipal Investigator - Saint Luke's Health System
Anderson County Hospital, Cardiovascular Consultants PC, Hedrick Medical Center, SLCC Inc., Saint Luke's Cushing Hospital, St. Luke's East Hospital, St. Luke's Northland Hospital-Barry Rd Campus, St. Luke's South Hosital, Wright Memorial Hospital
St Louis University School Of Medicine (Medical School)
University Of Mi Hosps (Residency)
3 Previous Clinical Trials
566 Total Patients Enrolled

Eligibility Criteria

Age 18 - 80 · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Is this study's target demographic older than middle-aged?

"The age range that this clinical trial's organizers are looking for is between 18-80 years old." - Anonymous Online Contributor

Unverified Answer

How many people total are involved in this experiment?

"The listings on show that this study is still open to patient recruitment, with the last update being on October 13th, 2021. This trial was first posted on April 9th, 2018 and is set to admit 75 patients from a single site." - Anonymous Online Contributor

Unverified Answer

Are patients able to enroll in this clinical trial at this time?

"The most recent update on shows that this study is still looking for patients. The first posting was on April 9th, 2018 and the last update was October 13th, 2021." - Anonymous Online Contributor

Unverified Answer

How can I sign up for this clinical trial?

"Tachycardia, ventricular and being between 18-80 years of age are the prerequisites for enrolling in this clinical trial. Right now, there are approximately 75 people who fit these qualifications." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.